Adverse drug reactions (ADRs) are a critical concern in clinical pharmacology, impacting patient safety and treatment efficacy. This book provides an in-depth analysis of the mechanisms, detection, and management of ADRs. It covers the pathways of drug-induced toxicity, risk factors, and strategies for minimizing adverse effects through pharmacogenomics and personalized medicine. With case studies and real-world examples, the book serves as a valuable resource for clinicians, pharmacologists, and healthcare professionals dedicated to improving drug safety and patient care.
Jacob Dunn is an expert dermatologist specializing in investigating adverse drug reactions (ADRs) related to dermatological treatments. His research focuses on identifying, documenting, and managing unexpected or harmful effects of medications used in treating skin conditions. Jacob has published extensively on the mechanisms, risk factors, and prevention strategies for ADRs in dermatology, emphasizing patient safety and treatment optimization. He has developed comprehensive ADR management protocols that enhance the monitoring and mitigation of adverse effects in dermatological therapies.